Back to Resource Hub Case Study

Solving Study Drug Dispensation Challenges with RTSM

A pharmaceutical company needed to ensure proper dispensation of their investigational product (IP) around variable visit schedules across multiple patient cohorts, as well as ensure each patient had sufficient doses to last until their next visit without incurring waste.

The company selected our Signant SmartSignals RTSM solution to help:

  • Maintain study balance across multiple strata and subgroups
  • Prevent IP allocation to duplicate subjects
  • Manage the return and destruction of supplies in all cases as needed, including early patient termination

Download the case study below and visit our RTSM page to learn more.

Similar posts

Looking for more insights? Explore related resources.

BROCHURE

RTSM Solution

SEE THE BROCHURE
BLOG POST

Revolutionizing Clinical Trial Supply Management with Signant SmartSignals® RTSM: Unveiling the Power of Free Picking

VISIT THE BLOG
CASE STUDY

Signant SmartSignals RTSM: Randomization and Cohort Management, IP Inventory Management

READ THE STUDY

Get notified on new marketing insights

Here mention the benefits of subscribing